Skip to content

ASBPW

Aspire Biopharma Holdings, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.01
+0.00%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-33.3%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jun 10, 2025Fell Donald G. · directorPurchase10,500$0.39
Jun 10, 2025Fell Donald G. · directorPurchase9,500$0.39
Jun 6, 2025Fell Donald G. · directorPurchase10,500$0.39
Jun 6, 2025Fell Donald G. · directorPurchase9,500$0.39
Aug 22, 2023PowerUp Sponsor LLC · 10 percent ownerSale4,317,500$0.00
Institutional positioning

13F filings over the trailing two quarters

New 2Increased 2Reduced 10Sold out 3
FilerActionSharesFiled
ADAGE CAPITAL PARTNERS GP, L.L.C.Unchanged1,050,000Aug 14, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.Unchanged1,050,000May 15, 2026
Saba Capital Management, L.P.Unchanged983,603Aug 14, 2026
SABA CAPITAL MANAGEMENT, L.P.Unchanged983,603May 15, 2026
LINDEN ADVISORS LPUnchanged899,999Aug 14, 2026
LINDEN ADVISORS LPUnchanged899,999May 15, 2026
ARISTEIA CAPITAL LLCUnchanged681,516May 15, 2026
ARISTEIA CAPITAL, L.L.C.Unchanged681,516Aug 14, 2026
TORONTO DOMINION BANKReduced516,345May 15, 2026
TORONTO DOMINION BANKReduced516,245Aug 14, 2026
SCULPTOR CAPITAL LPUnchanged500,000May 15, 2026
Sculptor Capital LPUnchanged500,000Aug 14, 2026
Clear Street Group Inc.Unchanged330,664Aug 12, 2026
CLEAR STREET GROUP INC.Reduced330,664May 15, 2026
MILLENNIUM MANAGEMENT LLCUnchanged275,000May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 10, 2025